Related Experiment Video
Updated: Nov 19, 2025

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
Published on: November 4, 2022
The Scientific Foundation of Chinese Herbal Medicine against COVID-19
Elaine Lai-Han Leung1, Hu-Dan Pan1, Yu-Feng Huang1
1State Key Laboratory of Quality Research in Chinese Medicine & Macau Institute for Applied Research in Medicine and Health & Faculty of Chinese Medicine, Macau University of Science and Technology, Macao 999078, China.
Insights
Traditional Chinese medicine offers potential therapeutic strategies for coronavirus disease 2019 (COVID-19), drawing from historical applications against similar viral infections. Further research is needed to confirm the efficacy of Chinese herbal formulas (CHFs) in combating COVID-19.
Area of Science:
- Virology and Immunology
- Traditional Chinese Medicine
- Pharmacology
Background:
- The COVID-19 pandemic presents a global health crisis, with SARS-CoV-2 sharing genomic similarities to SARS-CoV and MERS-CoV.
- COVID-19 progression involves viral infection, immune suppression, cytokine storm, multi-organ damage, and lung fibrosis.
- Limited specific treatments necessitate exploring alternative and complementary therapeutic strategies.
Purpose of the Study:
- To review and summarize the potential uses and therapeutic mechanisms of Chinese herbal formulas (CHFs) for COVID-19.
- To examine CHFs and patent drugs recommended in China for treating COVID-19.
- To verify the scientific basis of CHFs in combating COVID-19 based on existing literature.
Main Methods:
- Literature review of reported studies on CHFs and their application in viral infections.
- Analysis of national and provincial-level recommended patent drugs in China for COVID-19 treatment.
- Synthesis of information on the pharmacological actions and therapeutic mechanisms of CHFs.
Main Results:
- COVID-19 shares genomic and pathogenic similarities with SARS-CoV and MERS-CoV, suggesting historical treatment strategies may be relevant.
- Traditional Chinese medicine, including CHFs, is considered a viable option for COVID-19 treatment, either independently or adjunctively.
- Existing literature and national recommendations suggest potential therapeutic benefits of specific CHFs against COVID-19.
Conclusions:
- CHFs possess potential therapeutic value in managing COVID-19 progression and symptoms.
- Historical experience and holistic pharmacological actions support the use of TCM in viral infections.
- Further high-tech and translational research, including clinical studies, is crucial to validate the efficacy of CHFs for COVID-19.
Abstract:
The recent coronavirus disease 2019 (COVID-19) pandemic outbreak has caused a serious global health emergency. Supporting evidence shows that COVID-19 shares a genomic similarity with other coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and that the pathogenesis and treatment strategies that were applied 17 years ago in combating SARS-CoV and other viral infections could be taken as references in today's antiviral battle. According to the clinical pathological features of COVID-19 patients, patients can suffer from five steps of progression, starting with severe viral infection and suppression of the immune system and eventually progressing to cytokine storm, multi-organ damage, and lung fibrosis, which is the cause of mortality. Therefore, early prevention of disease progression is important. However, no specific effective drugs and vaccination are currently available, and the World Health Organization is urging the development of novel prevention and treatment strategies. Traditional Chinese medicine could be used as an alternative treatment option or in combination with Western medicine to treat COVID-19, due to its basis on historical experience and holistic pharmacological action. Here, we summarize the potential uses and therapeutic mechanisms of Chinese herbal formulas (CHFs) from the reported literature, along with patent drugs that have been recommended by institutions at the national and provincial levels in China, in order to verify their scientific foundations for treating COVID-19. In perspective, more basic and clinical studies with multiple high-tech and translational technologies are suggested to further confirm the therapeutic efficacies of CHFs.
More Related Videos
08:07Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments
Published on: May 31, 2017
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025